DR. DIETRICH MULLER GMBH – Trademark Portfolio
Entity Type: 16
DR. DIETRICH MULLER GMBH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 17 (Rubber Goods) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TACPHAN and SONOPHAN. The owner is based in AHLHORN-GROBENKNETEN.
ZEPPELINRING 18
AHLHORN-GROBENKNETEN 26197 , DE
Showing of trademarks Trademarks
Trademark Classifications
DR. DIETRICH MULLER GMBH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does DR. DIETRICH MULLER GMBH have?
DR. DIETRICH MULLER GMBH has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does DR. DIETRICH MULLER GMBH file in?
DR. DIETRICH MULLER GMBH files trademarks across 4 Nice Classification classes. The most active classes are Class 17 (Rubber Goods), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 17 covers unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica.
What are DR. DIETRICH MULLER GMBH's most well-known trademarks?
DR. DIETRICH MULLER GMBH's registered trademark portfolio includes well-known marks such as TACPHAN and SONOPHAN. These are among 2 currently registered trademarks in the portfolio.
What is DR. DIETRICH MULLER GMBH's trademark registration success rate?
DR. DIETRICH MULLER GMBH has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.